Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Susan Panozzo"'
Autor:
Frits van Rhee, Bart Barlogie, Gareth Morgan, Jeffrey Sawyer, John Crowley, Antje Hoering, Clyde Bailey, Susan Panozzo, Douglas Steward, Nathan Petty, Michele Cottler-Fox, Monica Grazziutti, Xenofon Papanikolaou, Rashid Khan, Sarah Waheed, Erming Tian, Shmuel Yaccoby, Maurizio Zangari, Joshua Epstein, Alan Mitchell, Yogesh S. Jethava
Supplementary Figure 1: Consort flow diagram of patient flow through TT4 arms Supplementary Figure 2: Cumulative Incidence of Death and Post-Relapse Survival (P-values for S-TT4 vs L-TT4; TRM, p = 0.61; MRM, p = 0.70; OIM, p = 0.25). Supplementary Fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::025a5709ef7051cd0c1b6aaf733cfad9
https://doi.org/10.1158/1078-0432.22457876
https://doi.org/10.1158/1078-0432.22457876
Autor:
Frits van Rhee, Bart Barlogie, Gareth Morgan, Jeffrey Sawyer, John Crowley, Antje Hoering, Clyde Bailey, Susan Panozzo, Douglas Steward, Nathan Petty, Michele Cottler-Fox, Monica Grazziutti, Xenofon Papanikolaou, Rashid Khan, Sarah Waheed, Erming Tian, Shmuel Yaccoby, Maurizio Zangari, Joshua Epstein, Alan Mitchell, Yogesh S. Jethava
Supplementary Table 1: Total Therapy 4 (TT4) protocol schema Supplementary Table 2: Adverse Events by Arm and Maximum NCI CTC Grade Supplementary Table 3: Top 51 gene probes distinguishing multiple myeloma with and without cytogenetic abnormalities (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15c3a8c8f359e69b0b924c1bf0cb619b
https://doi.org/10.1158/1078-0432.22457873.v1
https://doi.org/10.1158/1078-0432.22457873.v1
Autor:
Susan Panozzo, Antje Hoering, James E. McDonald, Niels Weinhold, Gareth J. Morgan, Sharmilan Thanendrarajan, Faith E. Davies, Doug Steward, Carolina Schinke, Frits van Rhee, Bart Barlogie, James A. Ntambi, Adam Rosenthal, Leo Rasche, Maurizio Zangari, Brian A Walker, Nathan Petty
Publikováno v:
Haematologica
Fluorine-18 fluorodeoxyglucose positron emission tomography with computed tomography attenuation correction (PET-CT) in myeloma can detect and enumerate focal lesions by the quantitative characterization of metabolic activity. The aim of this study w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcb37148b3c2e78ff4903a243d918871
http://europepmc.org/articles/PMC6058800
http://europepmc.org/articles/PMC6058800
Autor:
Clyde Bailey, Alan Mitchell, Douglas Steward, Erming Tian, Rashid Z Khan, Shmuel Yaccoby, Monica Grazziutti, Frits van Rhee, Gareth J. Morgan, Michele Cottler-Fox, Jeffrey R. Sawyer, Xenofon Papanikolaou, Bart Barlogie, Antje Hoering, John Crowley, Nathan Petty, Maurizio Zangari, Joshua Epstein, Sarah Waheed, Susan Panozzo, Yogesh Jethava
Publikováno v:
Clinical Cancer Research. 23:2665-2672
Purpose: To determine whether a reduction in the intensity of Total Therapy (TT) reduces toxicity and maintains efficacy. Experimental Design: A total of 289 patients with gene expression profiling (GEP70)-defined low-risk multiple myeloma were rando
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0b23dd5997a955d70847f88bbf62e74
https://doi.org/10.1158/1078-0432.ccr-15-2620
https://doi.org/10.1158/1078-0432.ccr-15-2620
Autor:
Susan Panozzo, Faith E. Davies, Joshua Epstein, Katherine K. Nishimura, Brian A Walker, Jeffery R. Sawyer, Doug Steward, Bart Barlogie, Antje Hoering, Adam Rosenthal, Carolina Schinke, Guido Tricot, Maurizio Zangari, Gareth J. Morgan, Frits van Rhee
Publikováno v:
Blood. 134:3309-3309
Introduction. Our TT regimens for newly diagnosed multiple myeloma (MM) incorporate novel agents into a sequential treatment program comprising induction, tandem autologous stem cell transplantation and consolidation followed by 3 years of maintenanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c381a862d5d7e7f88a5eb90fa445d6f3
https://doi.org/10.1182/blood-2019-131870
https://doi.org/10.1182/blood-2019-131870
Autor:
Kelly L. Stratton, Bart Barlogie, Emily Hansen, Qing Zhang, John Crowley, Douglas Steward, Antje Hoering, van Rhee F, Sarah Waheed, Nathan Petty, Saad Z. Usmani, Shmuel Yaccoby, Susan Panozzo, Pingping Qu
Publikováno v:
Leukemia. 28:2413-2415
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ce32f4e314aa139b0f7dc0431fbb0f6
https://doi.org/10.1038/leu.2014.248
https://doi.org/10.1038/leu.2014.248
Autor:
Natalia Lapteva, Justin Stivers, Bijay Nair, Adrian P. Gee, Katie L. Stone, Susan Panozzo, Sarah Waheed, Frits van Rhee, Dario Campana, Susann Szmania, William T. Bellamy, Tarun K. Garg, Michele Cottler-Fox, Cliona M. Rooney, Emily Woods, Junaid A. Khan, Joshua Epstein, Molly Robbins, Amy D Greenway, Joshuah D Lingo, Shmuel Yaccoby, Bart Barlogie
Highly activated/expanded natural killer (NK) cells can be generated by stimulation with the human leukocyte antigen-deficient cell line K562, genetically modified to express 41BB-ligand and membrane-bound interleukin (IL)15. We tested the safety, pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b678cc01f6df65abd266e96161e48129
https://europepmc.org/articles/PMC4352951/
https://europepmc.org/articles/PMC4352951/
Autor:
Antje Hoering, Susan Panozzo, Jeffery R. Sawyer, Xenofon Papanikolaou, Bart Barlogie, Alan Mitchell, Yogesh Jethava, Monica Grazziutti, Rashid Z Khan, Frits van Rhee, Sharmilan Thanendrarajan, Faith E. Davies, Christoph Heuck, John Crowley, Nathan Petty, Sarah Waheed, Maurizio Zangari, Gareth J. Morgan, Douglas Steward, Clyde Bailey, Carolina Schinke
Publikováno v:
Blood. 126:3181-3181
Introduction: Total Therapy 4 (TT4) comprises a randomized phase III trial enrolling 289 patients with gene expression profiling defined low-risk MM in which patients were allocated to a standard arm (TT4-S) or a light arm (TT4-L) with as principal g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::996a2b7baf05f995eb6b07cff668e0b9
https://doi.org/10.1182/blood.v126.23.3181.3181
https://doi.org/10.1182/blood.v126.23.3181.3181
Autor:
Susan Panozzo, Saad Z. Usmani, A Tullos, Shebli Atrash, F. van Rhee, Bart Barlogie, Manisha Bhutani
Publikováno v:
Blood Cancer Journal
Carfilzomib is a novel, highly selective, tetrapeptide epoxyketone proteasome inhibitor that irreversibly binds to the N-terminal threonine-containing active sites of the 20S proteasome, which is the proteolytic core particle within the 26S proteasom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d72e7d68fbc2737ead0cdb7078f6587b
https://doi.org/10.1038/bcj.2014.93
https://doi.org/10.1038/bcj.2014.93
Autor:
Faith E. Davies, Susan Panozzo, Carolina Schinke, Yogesh Jethava, Xenofon Papanikolaou, Christoph Heuck, Maurizio Zangari, Frits van Rhee, Gareth J. Morgan, Bart Barlogie, Clyde Bailey, Adam Rosenthal, Rashid Z Khan
Publikováno v:
Blood. 124:2128-2128
Despite the increasing availability of novel agents for RRMM, many patients run out of treatment options due to disease refractoriness and/or progressive toxicities, both hematological (cytopenia) and non-hematological (cachexia, asthenia, renal and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fdc49768469bf456911f1d69f5a5b935
https://doi.org/10.1182/blood.v124.21.2128.2128
https://doi.org/10.1182/blood.v124.21.2128.2128